SG133452A1 - Peptide deformylase inhibitors for treatment of mycobacterial and other parasitic diseases - Google Patents
Peptide deformylase inhibitors for treatment of mycobacterial and other parasitic diseasesInfo
- Publication number
- SG133452A1 SG133452A1 SG200508608-7A SG2005086087A SG133452A1 SG 133452 A1 SG133452 A1 SG 133452A1 SG 2005086087 A SG2005086087 A SG 2005086087A SG 133452 A1 SG133452 A1 SG 133452A1
- Authority
- SG
- Singapore
- Prior art keywords
- mycobacterial
- treatment
- parasitic diseases
- peptide deformylase
- deformylase inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG200508608-7A SG133452A1 (en) | 2005-12-30 | 2005-12-30 | Peptide deformylase inhibitors for treatment of mycobacterial and other parasitic diseases |
| ARP060105821A AR058769A1 (es) | 2005-12-30 | 2006-12-27 | Inhibidores de peptidil-deformilasa(pdf),utiles para el tratamiento de la tuberculosis y composiciones farmaceuticas que los contienen. |
| CNA2006800494397A CN101346370A (zh) | 2005-12-30 | 2006-12-28 | Pdf抑制剂 |
| US12/159,429 US20090318445A1 (en) | 2005-12-30 | 2006-12-28 | Pdf inhibitors |
| RU2008130925/04A RU2008130925A (ru) | 2005-12-30 | 2006-12-28 | Ингибиторы |
| AU2006334391A AU2006334391A1 (en) | 2005-12-30 | 2006-12-28 | PDF inhibitors |
| KR1020087015780A KR20080077655A (ko) | 2005-12-30 | 2006-12-28 | Ｐｄｆ 억제제 |
| PCT/EP2006/070234 WO2007077186A1 (en) | 2005-12-30 | 2006-12-28 | Pdf inhibitors |
| BRPI0620655-7A BRPI0620655A2 (pt) | 2005-12-30 | 2006-12-28 | inibidores de pdf |
| PE2006001710A PE20071061A1 (es) | 2005-12-30 | 2006-12-28 | Derivados de carbonilo como inhibidores de peptidil-deformilasa (pdf) |
| JP2008547967A JP2009522232A (ja) | 2005-12-30 | 2006-12-28 | Ｐｄｆインヒビター |
| CA002629148A CA2629148A1 (en) | 2005-12-30 | 2006-12-28 | Pdf inhibitors |
| EP06830830A EP1973898A1 (en) | 2005-12-30 | 2006-12-28 | Pdf inhibitors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG200508608-7A SG133452A1 (en) | 2005-12-30 | 2005-12-30 | Peptide deformylase inhibitors for treatment of mycobacterial and other parasitic diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG133452A1 true SG133452A1 (en) | 2007-07-30 |
Family
ID=37865850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200508608-7A SG133452A1 (en) | 2005-12-30 | 2005-12-30 | Peptide deformylase inhibitors for treatment of mycobacterial and other parasitic diseases |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090318445A1 (es) |
| EP (1) | EP1973898A1 (es) |
| JP (1) | JP2009522232A (es) |
| KR (1) | KR20080077655A (es) |
| CN (1) | CN101346370A (es) |
| AR (1) | AR058769A1 (es) |
| AU (1) | AU2006334391A1 (es) |
| BR (1) | BRPI0620655A2 (es) |
| CA (1) | CA2629148A1 (es) |
| PE (1) | PE20071061A1 (es) |
| RU (1) | RU2008130925A (es) |
| SG (1) | SG133452A1 (es) |
| WO (1) | WO2007077186A1 (es) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8329159B2 (en) | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7759495B2 (en) | 2006-08-11 | 2010-07-20 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7745636B2 (en) | 2006-08-11 | 2010-06-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8303944B2 (en) | 2006-08-11 | 2012-11-06 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7659270B2 (en) | 2006-08-11 | 2010-02-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| TW200831084A (en) * | 2006-11-21 | 2008-08-01 | Genelabs Tech Inc | Anti-viral compounds |
| US7741347B2 (en) | 2007-05-17 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7728027B2 (en) | 2007-08-08 | 2010-06-01 | Bristol-Myers Squibb Company | Process for synthesizing compounds useful for treating hepatitis C |
| US8629171B2 (en) | 2007-08-08 | 2014-01-14 | Bristol-Myers Squibb Company | Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt |
| JP2011511841A (ja) | 2008-02-12 | 2011-04-14 | ブリストル−マイヤーズ スクイブ カンパニー | Ｃ型肝炎ウイルス阻害剤 |
| US8147818B2 (en) | 2008-02-13 | 2012-04-03 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7704992B2 (en) * | 2008-02-13 | 2010-04-27 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7906655B2 (en) | 2008-08-07 | 2011-03-15 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8383094B2 (en) | 2008-10-01 | 2013-02-26 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8394968B2 (en) | 2009-02-17 | 2013-03-12 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| TWI438200B (zh) | 2009-02-17 | 2014-05-21 | 必治妥美雅史谷比公司 | Ｃ型肝炎病毒抑制劑 |
| US8796466B2 (en) | 2009-03-30 | 2014-08-05 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| EP2332562A3 (en) * | 2009-04-09 | 2011-09-28 | Universität zu Köln | Therapeutic agents for the treatment of tuberculosis, especially pulmonary tuberculosis |
| TW201038559A (en) | 2009-04-09 | 2010-11-01 | Bristol Myers Squibb Co | Hepatitis C virus inhibitors |
| US8143414B2 (en) | 2009-04-13 | 2012-03-27 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8138215B2 (en) | 2009-05-29 | 2012-03-20 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8211928B2 (en) | 2009-05-29 | 2012-07-03 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8242284B1 (en) * | 2009-09-21 | 2012-08-14 | The United States Of America As Represented By The United States Department Of Energy | Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making |
| US20110274648A1 (en) | 2009-11-11 | 2011-11-10 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
| US20110269956A1 (en) | 2009-11-11 | 2011-11-03 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
| US20110281910A1 (en) | 2009-11-12 | 2011-11-17 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
| US8377980B2 (en) | 2009-12-16 | 2013-02-19 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8362020B2 (en) | 2009-12-30 | 2013-01-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| EA201591390A1 (ru) | 2010-06-24 | 2016-06-30 | Джилид Сайэнс, Инк. | Пиразол[1,5-a]пиримидины для противовирусного лечения |
| US8552047B2 (en) | 2011-02-07 | 2013-10-08 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US9546160B2 (en) | 2011-05-12 | 2017-01-17 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| EP2794611B1 (en) | 2011-12-22 | 2017-10-11 | Gilead Sciences, Inc. | Pyrazolo[1,5-a]pyrimidines as antiviral agents |
| US9326973B2 (en) | 2012-01-13 | 2016-05-03 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| CN106986869A (zh) | 2012-04-17 | 2017-07-28 | 吉利德科学公司 | 用于抗病毒治疗的化合物和方法 |
| US9717712B2 (en) | 2013-07-02 | 2017-08-01 | Bristol-Myers Squibb Company | Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus |
| US20150023913A1 (en) | 2013-07-02 | 2015-01-22 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
| JP2016527232A (ja) | 2013-07-17 | 2016-09-08 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Ｈｃｖの治療に使用するためのビフェニル誘導体を含む組み合わせ |
| WO2015031710A1 (en) * | 2013-08-29 | 2015-03-05 | Baylor College Of Medicine | Compositions and methods for the treatment of metabolic and body weight related disorders |
| US10617675B2 (en) | 2015-08-06 | 2020-04-14 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| EP3372601B1 (en) | 2015-10-22 | 2022-09-21 | Mitsubishi Tanabe Pharma Corporation | Novel bicyclic heterocyclic compound |
| ES2930814T3 (es) | 2016-05-11 | 2022-12-22 | Guangdong Hebo Pharmaceutical Co Ltd | Inhibidor de péptido deformilasa de anillo espiro de tres miembros o anillo espiro de cinco miembros y uso del mismo como agente antitumoral |
| WO2020120576A1 (en) * | 2018-12-11 | 2020-06-18 | Fundació Institut De Recerca Biomèdica (Irb Barcelona) | p38α AUTOPHOSPHORYLATION INHIBITORS |
| CN109851614B (zh) * | 2019-03-29 | 2023-01-13 | 中山大学 | 一类杂环类肽脱甲酰基酶抑制剂及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0623190B2 (ja) * | 1985-04-16 | 1994-03-30 | サントリー株式会社 | インヒビタ−活性を有するｎ−アシルピロリジン誘導体及びその製法並びに用途 |
| AU2268401A (en) * | 1999-12-17 | 2001-06-25 | Versicor Inc | Novel succinate compounds, compositions and methods of use and preparation |
| ATE360014T1 (de) * | 2001-06-15 | 2007-05-15 | Vicuron Pharm Inc | Bicyclische pyrrolidinverbindungen |
| AR036053A1 (es) * | 2001-06-15 | 2004-08-04 | Versicor Inc | Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas |
| GT200600196A (es) * | 2005-05-23 | 2007-01-15 | Compuestos n-formil de hidroxilamina |
-
2005
- 2005-12-30 SG SG200508608-7A patent/SG133452A1/en unknown
-
2006
- 2006-12-27 AR ARP060105821A patent/AR058769A1/es unknown
- 2006-12-28 KR KR1020087015780A patent/KR20080077655A/ko not_active Application Discontinuation
- 2006-12-28 CA CA002629148A patent/CA2629148A1/en not_active Abandoned
- 2006-12-28 CN CNA2006800494397A patent/CN101346370A/zh active Pending
- 2006-12-28 AU AU2006334391A patent/AU2006334391A1/en not_active Abandoned
- 2006-12-28 WO PCT/EP2006/070234 patent/WO2007077186A1/en active Application Filing
- 2006-12-28 BR BRPI0620655-7A patent/BRPI0620655A2/pt not_active IP Right Cessation
- 2006-12-28 RU RU2008130925/04A patent/RU2008130925A/ru not_active Application Discontinuation
- 2006-12-28 US US12/159,429 patent/US20090318445A1/en not_active Abandoned
- 2006-12-28 EP EP06830830A patent/EP1973898A1/en not_active Withdrawn
- 2006-12-28 JP JP2008547967A patent/JP2009522232A/ja active Pending
- 2006-12-28 PE PE2006001710A patent/PE20071061A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20071061A1 (es) | 2007-12-06 |
| US20090318445A1 (en) | 2009-12-24 |
| WO2007077186A8 (en) | 2007-11-15 |
| KR20080077655A (ko) | 2008-08-25 |
| CN101346370A (zh) | 2009-01-14 |
| CA2629148A1 (en) | 2007-07-12 |
| AR058769A1 (es) | 2008-02-20 |
| WO2007077186A1 (en) | 2007-07-12 |
| EP1973898A1 (en) | 2008-10-01 |
| BRPI0620655A2 (pt) | 2011-11-22 |
| JP2009522232A (ja) | 2009-06-11 |
| AU2006334391A1 (en) | 2007-07-12 |
| RU2008130925A (ru) | 2010-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG133452A1 (en) | Peptide deformylase inhibitors for treatment of mycobacterial and other parasitic diseases | |
| IL193473A0 (en) | Amide derivatives and their application for the treatment of g protein related diseases | |
| HK1139036A1 (en) | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases | |
| EP1804813A4 (en) | FORMULATIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| GB0421525D0 (en) | Inhibitors of protein kineses | |
| IL183115A0 (en) | Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases | |
| IL177308A0 (en) | Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential | |
| DK3323815T3 (en) | Human Protein Tyrosine Phosphatase Inhibitors and Methods of Use | |
| IL176960A0 (en) | Compositions and methods of treatment for inflammatory diseases | |
| EP1765379A4 (en) | CO-CRISTAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | |
| IL196129A0 (en) | Human protein tyrosine phosphatase inhibitors and methods of use | |
| IL191600A (en) | A specific neutralizing antibody against il-6 from a person and various aspects related to it | |
| IL196130A0 (en) | Human protein tyrosine phosphatase inhibitors and methods of use | |
| IL190201A0 (en) | Pde inhibitors and combinations thereof for the treatment of urological disorders | |
| IL184735A0 (en) | Pharmaceutical formulations and methods of use | |
| EP1812012A4 (en) | PROTEIN TYROSINE PHOSPHATASE INHIBITOR AND METHOD FOR THEIR USE | |
| EP1922086A4 (en) | TARGETED PROTEIN KINASE C HEMMER AND ITS USES | |
| IL185457A0 (en) | 5-phenyl-pentanoic acid derivatives as metrix metalloproteinase inhibitors for the treatment of asthma and other diseases | |
| HK1171972A1 (zh) | 治療疾病的方法和產品 | |
| EP2225196A4 (en) | CYSTONE PROTEASE INHIBITOR FOR THE TREATMENT OF PARASITIC DISEASES | |
| EP1909784A4 (en) | CYSTEIN PROTEASE HEMMER OF THE PAPAIN FAMILY FOR THE TREATMENT OF PARASITIC ILLNESSES | |
| IL175412A0 (en) | Use of specific histones for the treatment of parasitic diseases | |
| EP1883404A4 (en) | P38 INHIBITORS AND METHODS OF USE | |
| ZA200707955B (en) | Methods and pharmaceutical compositions for the treatment of neurological damage | |
| EP1682115A4 (en) | HIF-1 HEMMER AND APPLICATION METHOD THEREFOR |